BC
KRON

Blackhill Capital’s Kronos Bio KRON Stock Holding History

Blackhill Capital’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,500
Closed -$178K – 55
2021
Q3 		$178K Hold
8,500
– – 0.02% 50
2021
Q2 		$204K Hold
8,500
– – 0.02% 50
2021
Q1 		$249K Hold
8,500
– – 0.02% 48
2020
Q4 		$254K Buy
+8,500
New +$267K 0.03% 48

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Blackhill Capital's KRON Position: Q4 2021 in Review

Blackhill Capital sold out of Kronos Bio (KRON) in Q4 2021, closing a stake of 8,500 shares — an estimated $178K sold.

Blackhill Capital first reported a position in KRON in Q4 2020 and held it in 4 quarters. The position peaked at $254K in Q4 2020. 81 funds tracked by Wall St. Rank hold KRON as of Q4 2021.

  • Blackhill Capital reported no remaining Kronos Bio position as of Q4 2021 after selling out during the quarter.
  • Blackhill Capital sold 8,500 Kronos Bio shares in Q4 2021, an estimated $178K.
  • Blackhill Capital first reported a position in Kronos Bio in Q4 2020 and held it in 4 quarters.
  • Blackhill Capital's Kronos Bio position peaked at $254K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2021.

Based on Blackhill Capital's 13F filing for Q4 2021, filed 11 Feb 2022.